My current research interests focus on studying the mechanisms of exosome-driven immunoregulatory pathways that alter the function of recipient immune cells and are associated with tumor progression and tumor resistance to therapies. Last but not least, I am very interested in developing novel therapeutic strategies that could overcome therapeutic resistance and induce tumor regression.